StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories non-GAAP Adjusted Gross Margin ($M) ($M)

Form 8-K Non-GAAP Reconciliation Tables

QuarterlyAnnual
Latest, FY2025
25,151
Period ended Dec 31, 2025
Change on a year earlier
+6.7%
23,579 in FY2024
History
12 years
Since FY2014
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Adjusted Gross Margin ($M) ($M)Year on yearSource
FY2025Dec 31, 202525,151+6.7%SEC Filing (0001628280-26-002982) ↗
FY2024Dec 31, 202423,579+5.8%SEC Filing (0001628280-26-002982) ↗
FY2023Dec 31, 202322,277-10.4%SEC Filing (0001628280-25-002092) ↗
FY2022Dec 31, 202224,849-0.5%SEC Filing (0001628280-24-002009) ↗
FY2021Dec 31, 202124,967+25.3%SEC Filing (0001628280-23-001516) ↗
FY2020Dec 31, 202019,925+5.6%SEC Filing (0001104659-22-007648) ↗
FY2019Dec 31, 201918,877+4.0%SEC Filing (0001104659-21-007942) ↗
FY2018Dec 31, 201818,147+12.3%SEC Filing (0001104659-20-005717) ↗
FY2017Dec 31, 201716,159+35.3%SEC Filing (0001104659-19-002848) ↗
FY2016Dec 31, 201611,940+1.1%SEC Filing (0001104659-18-003691) ↗
FY2015Dec 31, 201511,812+5.5%SEC Filing (0001104659-17-003920) ↗
FY2014Dec 31, 201411,195–SEC Filing (0001104659-16-091861) ↗

Cite this data

StockData. (2026). Abbott Laboratories Non-GAAP Adjusted Gross Margin ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ng-gross-margin

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.